DNB
58
2
KHC
22
2
EL
34
-3
GIS
49
12
AAP
29
-3
XRX
52
3
FCX
50
-2
PFG
27
-3
AZO
62
4
RF
47
3
SCHW
53
-11
DIS
72
-5
ZION
57
-3
FDX
34
-2
STZ
54
2
CVX
23
-2
QCOM
55
2
WHR
70
-2
KEY
31
2
WFC
58
-2
DNB
58
2
KHC
22
2
EL
34
-3
GIS
49
12
AAP
29
-3
XRX
52
3
FCX
50
-2
PFG
27
-3
AZO
62
4
RF
47
3
SCHW
53
-11
DIS
72
-5
ZION
57
-3
FDX
34
-2
STZ
54
2
CVX
23
-2
QCOM
55
2
WHR
70
-2
KEY
31
2
WFC
58
-2
Financhill
Back

Cyclerion Therapeutics Quote, Financials, Valuation and Earnings

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Buy
55

CYCN
Cyclerion Therapeutics

Last Price:
3.40
Seasonality Move:
10.81%

7 Day Trial

ALL ACCESS PASS

$ 7

The dark truth about AI

Click here to learn more...

Cyclerion Therapeutics Price Quote

$3.40
-0.03 (-4.76%)
(Updated: December 14, 2024 at 5:29 AM ET)

Cyclerion Therapeutics Key Stats

Buy
55
Cyclerion Therapeutics (CYCN) is a Buy
Day range:
$3.11 - $3.56
52-week range:
$1.27 - $9.47
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.13%
Volume:
81.5K
Avg. volume:
6.5M
1-year change:
20.35%
Market cap:
$9.3M
Revenue:
$0
EPS:
$-2.14

How Much Does Cyclerion Therapeutics Make?

Data Unavailable

Is Cyclerion Therapeutics Growing As A Company?

Data Unavailable

Cyclerion Therapeutics Stock Price Performance

What Is Cyclerion Therapeutics 52-Week High & Low?

Cyclerion Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cyclerion Therapeutics?

Is Cyclerion Therapeutics Cash Flow Positive?

  • What Is CYCN Cash Flow From Operations?
    Cash flow from operations (TTM) is -$6.2M
  • What Is Cyclerion Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $0
  • What Is Cyclerion Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Cyclerion Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    CYCN return on invested capital is -51.71%
  • What Is Cyclerion Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -44.82%
  • What Is CYCN Return On Equity?
    ROE is a measure of profitability and is -51.71%

Cyclerion Therapeutics Earnings Date & Stock Price

Cyclerion Therapeutics Competitors

Cyclerion Therapeutics Dividend Yield

Cyclerion Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 31.43%
Revenue: 0% -100%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 80.00
Upside from Last Price: 2232.36%

Major Shareholders

  • How many CYCN shares are owned by institutional investors?
    1.4M CYCN shares are owned by institutional investors
  • How many CYCN shares are owned by insiders?
    1.3M CYCN shares are owned by insiders